Post-IPO Equity - Chemomab
Investment Firm
Overview
Chemomab is a clinical-stage biotech company focusing on the discovery and development of innovative therapeutics.
Announced Date
Mar 16, 2021
Funding Type
Post Ipo Equity
Highlights
N/A
Location
N/A
Social
N/A
Investor Lead
Presight Capital
Presight Capital is a early_stage_venture and late_stage_venture and seed firm.
Apeiron Investment Group
Apeiron Investment Group is a early_stage_venture and late_stage_venture and post_ipo and seed and venture firm.
Cormorant Asset Management
Cormorant Asset Management is a early_stage_venture and late_stage_venture and post_ipo and private_equity and venture firm.
Participant Investors
5
Round Details and Background
Chemomab raised $45500000 on 2021-03-16 in Post-IPO Equity
Chemomab is a clinical-stage biotech company focusing on the discovery and development of innovative therapeutics.
Company Funding History
5
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Sep 03, 2016 | 1 | - | 5.0M | |
| Dec 01, 2019 | 4 | - | 20.0M | |
| Mar 16, 2021 | 5 | - | 45.5M | |
| Jul 25, 2024 | 3 | - | 10.0M |
Recent Activity
There is no recent news or activity for this profile.